These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20166063)

  • 21. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD005431. PubMed ID: 30640411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-vascular endothelial growth factor for neovascular glaucoma.
    Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
    Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iridotomy to slow progression of visual field loss in angle-closure glaucoma.
    Le JT; Rouse B; Gazzard G
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012270. PubMed ID: 29897635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
    Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
    J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of medical intervention for normal tension glaucoma.
    Cheng JW; Cai JP; Wei RL
    Ophthalmology; 2009 Jul; 116(7):1243-9. PubMed ID: 19450880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needling for encapsulated trabeculectomy filtering blebs.
    Feyi-Waboso A; Ejere HO
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003658. PubMed ID: 22895936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for idiopathic intracranial hypertension.
    Piper RJ; Kalyvas AV; Young AM; Hughes MA; Jamjoom AA; Fouyas IP
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD003434. PubMed ID: 26250102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
    Ulaş F; Balbaba M; Çelebi S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of latanoprost in eyes with uveitic glaucoma.
    Markomichelakis NN; Kostakou A; Halkiadakis I; Chalkidou S; Papakonstantinou D; Georgopoulos G
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):775-80. PubMed ID: 19184081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ab interno supraciliary microstent surgery for open-angle glaucoma.
    Sandhu A; Jayaram H; Hu K; Bunce C; Gazzard G
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012802. PubMed ID: 34049422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.
    Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
    Br J Ophthalmol; 2007 Jan; 91(1):62-8. PubMed ID: 16956912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD005431. PubMed ID: 21249670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four years later: a clinical update on latanoprost.
    Ravinet E; Mermoud A; Brignoli R
    Eur J Ophthalmol; 2003 Mar; 13(2):162-75. PubMed ID: 12696636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
    Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
    J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
    Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
    Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ab interno trabecular bypass surgery with iStent for open-angle glaucoma.
    Le JT; Bicket AK; Wang L; Li T
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012743. PubMed ID: 30919929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Ramchand K; Lindsley K
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006539. PubMed ID: 20166085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.
    Foo VHX; Htoon HM; Welsbie DS; Perera SA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011875. PubMed ID: 30999387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.